November 15, 2021 (Ottawa/Toronto) JDRF Canada and Canada’s Stem Cell Network are pleased to announce the JDRF-SCN National Fellowship Program in Type 1 Diabetes, a new opportunity for high-calibre postdocs from across Canada with expertise in stem cells, regenerative medicine, immunology or related fields to join the JDRF Centre of Excellence at the University of British Columbia (UBC) to pursue research focused on treating and curing type […]
JDRF Canada marks National Diabetes Awareness Month by launching new Monster Tamer Campaign
Toronto, ON — November 10, 2021 – JDRF Canada, the leading organization funding type 1 diabetes (T1D) research, is marking November and National Diabetes Awareness Month (NDAM) with a new Monster Tamer Campaign. T1D is an autoimmune disease that many have said can feel like living with a monster – a monster that requires you to […]
JDRF and Sun Life challenge corporate Canada to move work aside and move for a cure
The Sun Life Ride to Defeat Diabetes for JDRF invites people across Canada to raise funds to support type 1 diabetes research TORONTO, Oct 5, 2021 – One of Canada’s top fundraising events will be taking place on October 7, 2021. For the second straight year, the Sun Life Ride to Defeat Diabetes for JDRF […]
Filling the Forgotten Gaps in Care – JDRF Canada Launches Strategy for Mental Health and Type 1 Diabetes
TORONTO, September 28, 2021 — 2021 marks the 100th anniversary of the discovery of insulin in Toronto. Earlier this year, in honour of this anniversary, JDRF Canada, the largest charitable funder of type 1 diabetes (T1D) research in Canada, launched its $100M Campaign to Accelerate to build upon a long legacy of outstanding Canadian diabetes research, accelerating towards cures […]
One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks
Health Canada has recalled a single lot of Eli Lilly Glucagon, as it may be contaminated. The lot number is D239382A, expiry May 10, 2022. Please check your glucagon kits and return it to the pharmacy if you have a vial with this lot number. All other lot numbers are fine. For more information, click here: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76507a-eng.php.
Manitoba implements expanded coverage for insulin pumps and advanced glucose monitors
This past spring, the province committed to providing public coverage for advanced glucose monitors, including continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) for people with T1D up to age 25. The commitment also included expanded coverage under the Manitoba Pediatric Insulin Pump Program by changing the eligible age limit from under 18 […]
JDRF Canada and Brain Canada partner to fund critical research on mental health and type 1 diabetes
JDRF Canada and Brain Canada are pleased to announce the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a new funding opportunity for Canadian researchers that aims to address mental health concerns in people with type 1 diabetes (T1D). 2021 marks the 100th anniversary since the discovery of insulin in Canada. Insulin has […]
BC Announces Coverage for Dexcom CGM Effective Today
“JDRF is grateful for the leadership the BC government has shown in taking this step towards Access for All and moving to cover continuous glucose monitoring under BC Pharmacare,” said Dave Prowten, President and CEO of JDRF Canada. British Columbia announced today that it will begin covering Dexcom G6 continuous glucose monitoring (CGM) for those […]
Virtual fundraiser unveiled in support of type 1 diabetes research
NEWS RELEASE TORONTO, ON — June 3, 2021 – The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that rallies the type 1 diabetes (T1D) community to unite and raise funds for T1D research. This year’s Walk is a family-friendly, virtual, and interactive event that will bring together […]
Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetes
TD Bank Group supports JDRF’s Access for All program through the TD Ready Commitment. May 26, 2021 – Each day, as many as 300,000 Canadians living with type 1 diabetes (T1D) will make up to 300 decisions about their care. A wrong decision could mean life or death. T1D is an autoimmune disease that occurs when the […]
Government of Canada invests $35M in research and a national framework for diabetes
JDRF Canada is grateful to the Government of Canada for its commitment to honouring the centenary of the discovery of insulin in the 2021 federal budget. The budget proposes an investment of $35M for research into type 1 diabetes, surveillance and prevention, and to work towards the development of a national framework for diabetes. Continued […]
Manitoba and Saskatchewan Announce Expanded Coverage for Diabetes Technology
Wednesday, April 7, 2021, Toronto, ON – “JDRF Canada applauds this week’s provincial government announcements out of Saskatchewan and Manitoba, which are expanding access to insulin pumps and continuous and flash glucose monitoring devices for those living with type 1 diabetes,” says Dave Prowten, president and CEO, JDRF Canada. In the budget announced Tuesday on April […]
